PARSIPPANY, N.J., Sept. 22, 2011 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today that Siggi Olafsson, Watson’s Executive Vice President, Global Generics, will provide an overview and update of the Company’s business at the Jefferies 2011 Global Healthcare Conference on Tuesday, September 27, 2011 at 9:20 am BST (4:20 am EDT) in London, England. The presentation will be webcast live and can be accessed on Watson Pharmaceuticals’ Investor Relations Website at http://ir.watson.com. The webcast can also be accessed at the following URL:
http://www.wsw.com/webcast/jeff62/wpi/
(Logo: http://photos.prnewswire.com/prnh/20100121/LA41294LOGO)
An archived version will be available approximately one hour after the live presentation ends and can be accessed at the same locations for 90 days.
About Watson Pharmaceuticals, Inc.
Watson Pharmaceuticals, Inc. is an integrated global specialty pharmaceutical company. The Company is engaged in the development, manufacturing, marketing and distribution of generic pharmaceuticals and specialized branded pharmaceutical products focused on Urology and Women’s Health. Watson has operations in many of the world’s established and growing international markets.
For press release and other company information, visit Watson Pharmaceuticals’ Web site at http://www.watson.com.
CONTACTS:
Investors:
Patty Eisenhaur
(862) 261-8141
Media:
Charlie Mayr
(862) 261-8030
SOURCE Watson Pharmaceuticals, Inc.
